期刊文献+

糖皮质激素诱导骨质疏松的诊治进展 被引量:7

下载PDF
导出
摘要 糖皮质激素(glucocorticoids,GC)具有强大的抗炎作用,被广泛应用于风湿免疫疾病、过敏性疾病、肾脏疾病和器官移植等治疗。GC诱导的骨质疏松(glucocorticosteroidinduced osteoporosis,GIOP)是长期应用糖皮质激素的患者中主要的副作用之一,是继发性骨质疏松的最常见原因。
出处 《中日友好医院学报》 2010年第5期307-310,共4页 Journal of China-Japan Friendship Hospital
  • 相关文献

参考文献27

  • 1Albrecht W,Isenegger P,Buergi E,et al.Glucocorticosteroidinduced spinal osteoporosis:scientific update on pathophysiology and treatment[J].Eur Spine,2006,15:1035-1049.
  • 2Kenneth G,Saag K.Glucocorticoid-induced osteoporosis[J].Endocrinol Metab Clin N Am,2003,32:135-157.
  • 3Gourlay M,Franceschini N,Sheyn Y.Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures[J].Clin Rheumatol,2007,26:144-153.
  • 4Dana B,Nguyen D,Nguyen PhD,et al.Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women[J].JAMA,2009,301:513-521.
  • 5Sadat A,Abdulmohsen H,Badar A,et al.Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy[J].Rheumatol,2010,6:82-88.
  • 6Fili S,Karalaki M,Schaller B.Therapeutic implications of osteoprotegerin[J].Cancer Cell Int,2009,9:26-31.
  • 7Yuzaburo I,Naok S,Shuichi S,et al.Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases[J].Clin Rheumatol,2008,27:909-912.
  • 8Yuen W,Kwok C,Qin L.Characteristics of age-related changes in bone compared between male and female reference chinese populations in hong kong:a PQCT study[J].Bone Miner Metabo,2010,15:42-44.
  • 9Chiodini I,Francucci M,Scillitani A.Decsitometry in glucocorticoid-induced osteoporosis[J].Endocrinol Invest,2008,31:33-37.
  • 10Chiodini I,Torlontano M,Carnevale V,et al.Skeletal involvement in adult patients with endogenous hypercortisolism[J].Endocrinol Invest,2008,31:267-276.

同被引文献142

  • 1夏丽华,黄汉林,邝守仁,刘惠芳,孔凌珍.三氯乙烯所致药疹样皮炎50例临床分析[J].中华劳动卫生职业病杂志,2004,22(3):207-210. 被引量:69
  • 2迟兰芹,张晨,宋明军,孙风翠.糖皮质激素受体基因G1666T多态性与原发性高血压的相关性[J].基础医学与临床,2006,26(1):70-73. 被引量:6
  • 3Weinstein RS, Clinical practice. Glucocorticoid-induced bone disease[J]. N Engl JMed, 2011,365(1):62-70.
  • 4North American Menopause Society. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American MenopauseSociety[J]. Menopause, 2006, 13(3): 340-367.
  • 5den Uyl D, Bultink IE, Lems WF. Advances in glucocorticoid-inducedosteoporosis[J].Curr Rheumatol Rep, 2011,13(3):233-240.
  • 6Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3supplementation prevents bone loss in the spine secondary to low-dose corticosteroids inpatients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial[J].Ann Intern Med, 1996,125(12):961-968.
  • 7Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D forcorticosteroid- induced osteoporosis[J].Cochrane Database Syst Rev,2000,(2):CD000952.
  • 8Buttgereit FR, Iipworth BJ. Optimised glucocorticoid therapy:the sharpe- ning of an old spear[ J~. Lancet,2005,365 (9461) :801-803.
  • 9Den Uyl DE, Lems WF. Advances in glucocorticoid-induced osteoporosis[J]. Curr Rheumatol Rep ,2011,13 (3) :233-240.
  • 10Stewart PM, Krozowski ZS. 11 beta-hydroxysteroid dehydrogenase [ J 1. Vitam Horm, 1999, 57:249-324.

引证文献7

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部